Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Todd Neale

January 11, 2024

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases

Todd Neale

December 06, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Cardiotoxicity Rare With Common GI Chemotherapy

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases

Most Patient-Reported Outcome Measures in CVD Fall Short

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

More Evidence Links Breast Arterial Calcification and CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content